New lung cancer drug boosts AstraZeneca as trials show improved survival rates

The British firm said yesterday that the drug, being developed with Japan's Daiichi Sankyo, could be 'an important new treatment for patients'.

Related Keywords

Singapore ,United Kingdom ,Japan ,British ,Daiichi Sankyo ,Pascal Soriot ,Susan Galbraith ,Astrazeneca ,Pfizer ,Sir Pascal Soriot ,